Aadi Bioscience Inc. (Aadi) is a biopharmaceutical company focused on precision therapies for genetically-defined cancers. We strive to unleash the potential of mTOR inhibition by employing precision medicine & nanoparticle technology to bring transformational therapies to cancer patients with mTOR pathway driver alterations. Our lead product has been FDA-approved for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors (PEComa). In March 2025, we became a wholly-owned subsidiary of KAKEN Pharmaceutical Co., Ltd., an R&D driven pharmaceutical company in Japan. A science-first mindset and patient-centric approach is always in our genes. Together with KAKEN, we continue to dedicate to developing products for cancers with mTOR pathway driver alterations. For more information, please visit: https://aadibio.com/ and https://www.kaken.co.jp/english/.
Looking for a particular Aadi Bioscience, Inc employee's phone or email?
Aadi Bioscience, Inc Questions
The Aadi Bioscience, Inc annual revenue was $25.1 million in 2026.
Brendan Delaney is the President and CEO at Aadi Bioscience of Aadi Bioscience, Inc.
46 people are employed at Aadi Bioscience, Inc.
Aadi Bioscience, Inc is based in Morristown, New Jersey.
The NAICS codes for Aadi Bioscience, Inc are [541, 54, 5417, 54171, 541713].
The SIC codes for Aadi Bioscience, Inc are [873, 283, 28, 87, 80].
Top Aadi Bioscience, Inc Employees
-
15+
-
Shin Teradaira
President at Aadi Bioscience, Inc
Morristown, NJ, US11 -
Loretta Itri
Chief Medical Officer at Aadi Bioscience, Inc
New York, NY, US25 -
Berta Grigorian
Vice President Clinical Operations at Aadi Bioscience, Inc
Los Angeles, CA, US12 -
45+
-
24
-
Eiichiro Sato
Vice President Corporate at Aadi Bioscience, Inc
Morris Plains, NJ, US1 -
Kelli Shannon
Head of Market Access at Aadi Bioscience, Inc
Louisville, KY, US21 -
Timothy Kline
Senior Director Regulatory Affairs at Aadi Bioscience, Inc
Philadelphia, PA, US25+ -
25
Related Companies
